WBR0767: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) Created page with "{{WBRQuestion |QuestionAuthor={{Rim}} |ExamType=USMLE Step 1 |MainCategory=Pharmacology |SubCategory=Musculoskeletal/Rheumatology |MainCategory=Pharmacology |SubCategory=Muscu..." |
Rim Halaby (talk | contribs) No edit summary |
||
Line 20: | Line 20: | ||
|MainCategory=Pharmacology | |MainCategory=Pharmacology | ||
|SubCategory=Musculoskeletal/Rheumatology | |SubCategory=Musculoskeletal/Rheumatology | ||
|Prompt=A 58 year old female patient presents to the physician's office for a mandibular lesion. Her past medical history is significant for breast cancer. She is currently receiving zoledronic acid for her osteoporosis. The physician suspects the patient is having bisphosphonate-related osteonecrosis of the jaw. What additional predisposing factor is most likely to be present | |Prompt=A 58 year old female patient presents to the physician's office for a mandibular lesion. Her past medical history is significant for breast cancer. She is currently receiving zoledronic acid for her osteoporosis. The physician suspects the patient is having bisphosphonate-related osteonecrosis of the jaw. What additional predisposing factor is most likely to be present that led to this patient's condition? | ||
|Explanation= Bisphosphonates are potent inhibitors of osteoclasts that are indicated for osteoporosis. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a n adverse drug reaction during bisphosphonate use. The main risk factor for BRONJ is: History of pental procedures and poor dental hygiene, such as tooth infections or dental extractions especially among patients who have undergone surgery of the maxillofacial region. Other factors that also seem to be associated are corticosteroid therapy, radiotherapy, diabetes mellitus, and peripheral vascular disease. | |Explanation= Bisphosphonates are potent inhibitors of osteoclasts that are indicated for osteoporosis. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a n adverse drug reaction during bisphosphonate use. The main risk factor for BRONJ is: History of pental procedures and poor dental hygiene, such as tooth infections or dental extractions especially among patients who have undergone surgery of the maxillofacial region. Other factors that also seem to be associated are corticosteroid therapy, radiotherapy, diabetes mellitus, and peripheral vascular disease. | ||
Revision as of 22:51, 30 October 2013
Author | [[PageAuthor::Rim Halaby, M.D. [1]]] |
---|---|
Exam Type | ExamType::USMLE Step 1 |
Main Category | MainCategory::Pharmacology |
Sub Category | SubCategory::Musculoskeletal/Rheumatology |
Prompt | [[Prompt::A 58 year old female patient presents to the physician's office for a mandibular lesion. Her past medical history is significant for breast cancer. She is currently receiving zoledronic acid for her osteoporosis. The physician suspects the patient is having bisphosphonate-related osteonecrosis of the jaw. What additional predisposing factor is most likely to be present that led to this patient's condition?]] |
Answer A | AnswerA::Personal history of dental problems |
Answer A Explanation | AnswerAExp::History of dental problems, such as dental extractions or tooth infections, is the main risk factor for BRONJ. |
Answer B | AnswerB::High-grade breast cancer on pathological analysis |
Answer B Explanation | AnswerBExp::The patient's breast cancer does not predispose the patient to BRONJ. |
Answer C | AnswerC::Personal history of corrosive esophagitis |
Answer C Explanation | [[AnswerCExp::Corrosive esophagitis may be an adverse effect of bisphosphonates. To prevent corrosive esophagitis, patients are asked to take bisphosphonates in the morning in a standing position while drinking plenty of water. Patients are instructed to stay standing for several minutes before lying in a supine position.]] |
Answer D | AnswerD::Personal history of heavy smoking |
Answer D Explanation | AnswerDExp::Smoking is not a risk factor for developing BRONJ. |
Answer E | AnswerE::Caucasian race |
Answer E Explanation | AnswerEExp::Caucasian race is not a risk factor for developing BRONJ. |
Right Answer | RightAnswer::A |
Explanation | [[Explanation::Bisphosphonates are potent inhibitors of osteoclasts that are indicated for osteoporosis. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a n adverse drug reaction during bisphosphonate use. The main risk factor for BRONJ is: History of pental procedures and poor dental hygiene, such as tooth infections or dental extractions especially among patients who have undergone surgery of the maxillofacial region. Other factors that also seem to be associated are corticosteroid therapy, radiotherapy, diabetes mellitus, and peripheral vascular disease.
Educational Objective: Bisphosphonate-related osteonecrosis of the jaw is associated with a personal history of poor dental problems. Reference:
Maerevoet M, Martin C, Duck L. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med. 2005; 353(1):99-102. |
Approved | Approved::No |
Keyword | WBRKeyword::dental, WBRKeyword::procedures, WBRKeyword::extraction, WBRKeyword::extractions, WBRKeyword::procedure, WBRKeyword::tooth, WBRKeyword::infection, WBRKeyword::infections, WBRKeyword::teeth, WBRKeyword::ostenoecrosis, WBRKeyword::jaw, WBRKeyword::bisphosphonate, WBRKeyword::zoledronic, WBRKeyword::acid, WBRKeyword::breast, WBRKeyword::cancer, WBRKeyword::lesion, WBRKeyword::mandible, WBRKeyword::mandibular, WBRKeyword::risk, WBRKeyword::factor, WBRKeyword::predisposing |
Linked Question | Linked:: |
Order in Linked Questions | LinkedOrder:: |